Behavioral effects of D-AP7 in rats subjected to experimental hypoxia

Polish Journal of Pharmacology

Volumn 55, Issue 3, 2003, Pages 337-344

  Nadlewska, Agnieszka ^a   Car, Halina ^a   Wiśniewska, Róza ^a   Hoły, Zdzisław ^a   Wiśniewski, Konstanty ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

D ( ) 2 amino 7 phosphonoheptanoic acid (D AP7); Elevated plus maze; Hypoxia; Locomotion; Passive avoidance; Rats

Indexed keywords

2 AMINO 7 PHOSPHONOHEPTANOIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MOVEMENT; BRAIN HYPOXIA; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; EXPERIMENTAL MODEL; EXPLORATORY BEHAVIOR; LEARNING; LOCOMOTION; MALE; MAZE TEST; MEMORY CONSOLIDATION; NONHUMAN; OPEN FIELD TEST; PASSIVE AVOIDANCE; RAT; TIME;

2-AMINO-5-PHOSPHONOVALERATE; ANIMALS; ANOXIA; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; MOTOR ACTIVITY; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0043032863     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Ader R., Weijnen J.A.W.M., Maleman P.: Retention of a passive avoidance responses as a function of the intensity and duration of the electric shock. Psychonomic Sci., 1972, 26, 125-132.
2. Aitken P.G., Balestrino M., Somjen G.G.: NMDA: lack of protective effect against hypoxic damage in CA1 region of hippocampal slices. Neurosci. Lett., 1988, 89, 187-192.
3. Allweis C., Gibbs M.E., Ng K.T., Hodge R.J.: Effects of hypoxia and memory consolidation. Implication for a multistage model of memory. Behav. Brain Res., 1984, 11, 117-121.
4. Cai Z., Rhodes P.G.: Intrauterine hypoxia-ischemia alters expression of the NMDA receptor in the young rat brain. Neurochem. Res., 2001, 26, 487-495.
5. Car H., Oksztel R., Nadlewska A., Wiśniewski K.: Baclofen prevents hypoxia-induced consolidation impairment for passive avoidance. Pharmacol. Res., 2001, 44, 329-335.
6. Car H., Wiśniewski K.: The effect of baclofen and D-AP7 on selected behavior in rats. Pharmacol. Biochem. Behav., 1998, 59, 685-689.
7. Castellano C., Cestari V., Ciamei A.: NMDA receptors and learning and memory processes. Curr. Drug Targets, 2001, 2, 273-283.
8. Collingridge G.L., Bliss T.V.P.: NMDA receptors -their role in long-term potentiation. Trends Neurosci., 1987, 10, 288-293.
9. Collingridge G.L., Singer W.: Excitatory amino acid receptors and synaptic plasticity. Trends Pharmacol. Sci., 1990, 11, 290-296.
10. Conn P.J., Pin J.-P.: Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol, Toxicol., 1997, 37, 205-237.
11. Cotman C.W., Monaghan D.T., Ottersen O.P., Storm-Mathisen J.: Anatomical organization of excitatory amino acid receptors and their pathways. Trends Neurosci., 1987, 10, 273-280.
12. Davis S., Brotchie J., Davies I.: Protection of striatal neurons by joint blockade of D1 and D2 receptor subtypes in an in vitro model of cerebral hypoxia. Exp. Neurol., 2002, 176, 229-236.
13. Gilbert M.E., Mack C.M.: The NMDA antagonist, MK-801, suppresses long-term potentiation, kindling, and kindling-induced potentiation in the perforant path of the unanesthetized rat. Brain Res., 1990, 519, 89-96.
14. Izquierdo I., Medina J.H.: Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures. Neurobiol. Learn. Mem., 1997, 68, 285-316.
15. Kim J.J., Decola J.P., Landeira-Fernandez J., Fanselow M.S.: N-methyl-D-aspartate receptor antagonist APV blocks acquisition but not expression of fear conditioning. Behav. Neurosci., 1991, 105, 126-133.
16. Kretschmer B.D.: Modulation of the mesolimbic dopamine system by glutamate: role of NMDA receptors. J. Neurochem., 1999, 73, 839-848.
17. Lynch M.A., Errington M.L., Clements M.P., Bliss T.V.P., Redini-Del Negro C., Laroche S.: Increases in glutamate release and phosphoinositide metabolism associated with long-term potentiation and classical conditioning. Prog. Brain Res., 1990, 83, 251-256.
18. Marini A.M., Choi J., Labutta R.: Synaptic deprivation and age-related vulnerability to hypoxic-ischemic neuronal injury. A hypothesis. Ann. NY Acad. Sci., 2001, 939, 238-253.
19. Martinez G., Ropero C., Funes A., Flores E., Landa A.I., Gargiulo P.A.: AP-7 into the nucleus accumbens disrupts acquisition but does not affect consolidation in a passive avoidance task. Physiol. Behav., 2002, 76, 205-212.
20. Matthies H.: Pharmacology of learning and memory. Trends Biochem. Sci., 1980, 1, 333-337.
21. Mishra O.P., Fritz K.I., Delivoria-Papadopoulos M.: NMDA receptor and neonatal hypoxic brain injury. Ment. Retard. Dev. Disabil. Res. Rev., 2001, 7, 249-253.
22. Miwa S., Fujiwara M., Inoue M., Fujiwara M.: Effects of hypoxia on the activities of noradrenergic and dopaminergic neurons in the rat brain. J. Neurochem., 1986, 47, 63-69.
23. Monaghan D.T., Bridges R.J., Cotman C.W.: The excitatory amino acid receptors: their classes, pharmacology and distinct properties in the function of the central nervous system. Ann. Rev. Pharmacol. Toxicol., 1989, 29, 365-402.
24. Mondadori C., Weiskrantz L., Buerki H., Petschke F., Fagg G.E.: NMDA receptor antagonists can enhance or impair learning performance in animals. Exp. Brain Res., 1989, 75, 449-456.
25. Moren S., Baudry M., Thompson R.F.: Differential effects of ketamine and MK-801 on the induction of long-term potentiation. NeuroReport, 1991, 2, 239-242.
26. Morris R.G.M., Anderson E., Lynch G.S., Baudy M.: Selective impairment of learning and blockade of long-term potentiation by a N-methyl-D-aspartate receptor antagonist, AP5. Nature, 1986, 319, 774.
27. Nadlewska A., Car H., Oksztel R., Wiśniewski K.: Effect of (S)-3,5-DHPG on learning, exploratory activity and anxiety in rats with experimental hypoxia. Pol. J. Pharmacol., 2002, 54, 11-18.
28. Nicholls D., Attwell D.: The release and uptake of excitatory amino acids. Trends Pharmacol. Sci., 1990, 11, 462-468.
29. Padovan C.M., Del Bel E.A., Guimaraes F.S.: Behavioral effects in the elevated plus maze of an NMDA antagonist injected into the dorsal hippocampus: influence of restraint stress. Pharmacol. Biochem. Behav., 2000, 67, 325-330.
30. Pastuszko A.: Metabolic responses of the dopaminergic system during hypoxia in newborn brain. Biochem. Med. Metab. Biol., 1994, 51, 1-15.
31. Pellow S., Chopin P., Briley M.: Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Meth., 1985, 14, 149-167.
32. Perkins M.N., Collins J.F., Stone T.W.: Isomers of 2-amino-7-phosphonoheptanoic acid as antagonists of neuronal excitans. Neurosci. Lett., 1982, 32, 65-68.
33. Rothman S.M., Olney J.W.: Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann. Neurol., 1986, 19, 105-111.
34. Saransaari P., Oja S.S.: Release of endogenous glutamate, aspartate, GABA, and taurine from hippocampal slices from adult and developing mice under cell-damaging conditions. Neurochem. Res., 1998, 23, 563-570.
35. Sattler R., Xiong Z., Lu W.-Y., MacDonald J.F., Tymianski M.: Distinct roles of synaptic and extrasynaptic NMDA receptors in excitotoxicity. J. Neurosci., 2000, 20, 22-33.
36. Scatton B.: The NMDA receptor complex. Fundam. Clin. Pharmacol., 1993, 7, 389-400.
37. Schmidt W.J.: Behavioural effects of NMDA-receptor antagonists. J. Neural Transm. Suppl., 1994, 43, 63-69.
38. Sebastiao A.M., de Mendonca A., Moreira T., Ribeiro J.A.: Activation of synaptic NMDA receptors by action potential-dependent release of transmitter during hypoxia impairs recovery of synaptic transmission on reoxygenation. J. Neurosci., 2001, 21, 8564-8571.
39. Simon R.P., Swan J.H., Griffiths T., Meldrum B.S.: Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science, 1984, 226, 850-852.
40. Watkins J.C., Evans R.H.: Excitatory amino acid transmitters. Annu. Rev. Pharmacol. Toxicol., 1981, 21, 165-204.
41. Wiśniewski K., Lutostańska A., Artemowicz B.: The role of NMDA receptors in central action of angiotensin II. Acta Physiol. Hung., 1996, 84, 347-348.
42. Xu X., Boshoven W., Lombardo B., Spranger J.: Comparison of amnestic effects of NMDA receptor antagonist MK-801 and nitric oxide synthase inhibitors: L-NAME and L-NOARG in goldfish. Behav. Neurosci., 1998, 112, 892-899.